JACOB HANNA: Open Payments
NPI 1093202475 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,446 in 68 payments from 17 companies in 2025. Trend: 2023 $666 · 2024 $773 · 2025 $1,446
Food & beverage: $1,446
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $205 |
| E.R. Squibb & Sons, L.L.C. | 8 | $149 |
| Teva Pharmaceuticals USA, Inc. | 6 | $113 |
| Otsuka America Pharmaceutical, Inc. | 5 | $110 |
| Alkermes, Inc. | 6 | $108 |
| Corium, LLC | 4 | $96 |
| Vanda Pharmaceuticals Inc. | 4 | $90 |
| Neurocrine BioSciences, Inc. | 3 | $81 |
| Axsome Therapeutics, Inc. | 3 | $81 |
| Janssen Pharmaceuticals, Inc | 3 | $78 |
Products named: CAPLYTA, COBENFY, ARISTADA, Azstarys, AUSTEDO XR, FANAPT, REXULTI, INGREZZA.
Industry payments across GA — which companies pay providers there.
